{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69545da8cb029db7575279fc/69545e25d0c0aeaf12d8f403?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Beyond Meat’s sophomore slump, Pfizer’s VIP-only drug cabinet, and The Athletic joins the 500 club","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69545da8cb029db7575279fc/92740fced6850bd4118ca08b66798d32.jpeg?height=200","description":"A new drug company hath been born — Pfizer is merging its portfolio of off-patent drugs (like Viagra and Lipitor) with epi-pen-maker Mylan. Beyond Meat’s earnings report had a good side and a dark side. And The Athletic’s subscription-only sports news biz model is winning the media industry with a new milestone.\nLearn more about your ad choices. Visit podcastchoices.com/adchoices","author_name":"Nick & Jack Studios"}